PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE
Europas 2014
Global Venture, Local Capital
European Technology Investors
PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE
Highlights
2013 was a busy year for DFJ Esprit
MTT Neul Horizon
 22 deals in...
PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE
Innovation Creates Opportunity
Major innovations in last ~10-15 years
 Broad...
PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE
Innovation Never Stops Creating Opportunity
4
Major innovations in next ~10-1...
PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE5
Entrepreneur
Networks:
Growth Technology
Companies in Europe
Invested
Capita...
PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE
Number of Small (< $ 5M) vs. Mid/late stage (> $ 5M) VC Deals – USA and Europ...
PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE
Established
Regional leaders
Pan-European
Brand names
The size of the bubble ...
PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE
2013 >$5m deals (VentureSource) including follow-ons announced
No Investor De...
PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE
CurrentInvestments
Enterprise
Software
Digital Media &
Internet
Hardware &
El...
PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE10
Secondaries: 9 portfolio Deals, 140+ Companies
August 2004
Acquisition of W...
PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE
For further information please contact:
Simon Cook – CEO , DFJ Esprit
Tel: +4...
Upcoming SlideShare
Loading in …5
×

Dfj esprit europas 2014 (2)

611 views

Published on

Europas DFJ Esprit background

Published in: Business, Economy & Finance
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
611
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
9
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Dfj esprit europas 2014 (2)

  1. 1. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE Europas 2014 Global Venture, Local Capital European Technology Investors
  2. 2. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE Highlights 2013 was a busy year for DFJ Esprit MTT Neul Horizon  22 deals in 2013, Top 3 most active later stage  7 news deals – Sweden, Denmark, Ireland x2, Finland x2, Austria  Lyst – Balderton/Accel upround, 6x growth forecast  Graze – 110k in 3 months in US launch, upping forecasts  $514m sale of Kana  Only UK Nasdaq IPO – Oxford Immunotec $390m Market Cap.  4 portfolio in Future50 IPO list – Horizon first out next week  Hired Gil Dibner from Index, promoted Scott Sage, Won VC of the year  DFJ network spin out – join board Graze 2
  3. 3. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE Innovation Creates Opportunity Major innovations in last ~10-15 years  Broadband  Wireless comms: Bluetooth/Wifi  Ubiquitous email  Touch interfaces  Electronic Ink  TV over internet  Cybersecurity  Internet ads and commerce / The Long Tail  Electric cars  Wind farms / solar farms  Smartphone/apps  Social Networks / Social Comms DFJE / DFJ Network Companies 3
  4. 4. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE Innovation Never Stops Creating Opportunity 4 Major innovations in next ~10-15 years  Internet of things: 50 bn devices  Social curated E-commerce: The Long Nose  Social enterprise  Personalised Medicine / Wellness  Cyberwarfare  Cloud / Realtime / Big data  End to end digital advertising / commerce  Software defined networks  Robots / AI / Cars / Vision  3D printers / DNA printers  Quantum / Post Moores law computing  Next Generation Space Industry  ??? DFJE / DFJ Network Companies
  5. 5. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE5 Entrepreneur Networks: Growth Technology Companies in Europe Invested Capital Our Investor Networks: LP, Governments, Corps & Angels Exit networks Global M&A buyersGlobal DFJ Network Primary Team Angel Team Secondary Team High IRR Returns Our Business: Connecting Networks Growth Developing Opportunities
  6. 6. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE Number of Small (< $ 5M) vs. Mid/late stage (> $ 5M) VC Deals – USA and Europe USA Seed / small Mid/late stage Europe Creating Opportunities in Europe (it’s the follow-on, stupid) 6
  7. 7. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE Established Regional leaders Pan-European Brand names The size of the bubble represents approximately total funds the firm has under management for Western Europe. US VCs investing in Europe 1-2 deals o Sequoia o KPCB o Bessemer o Foundation o DAG o IVP o Greylock o Battery o Insight o And others NB: Excluding corporate, CleanTech & Life Science funds Scandinavia Benelux Spain France Germany/Swiss UK/Ireland Accel Europe Incl. Israel & Russia Balderton Mangrove Northzone Ventures Earlybird DFJ ESPRIT Verdane Index Ventures Incl. US/Israel SEP DN Prime Kennet Incl. US Partech Sunstone Innovacom Atomico (Global) Creandum Notion IDinvest Iris Highland EuropeHoltzsbrink DawnNauta Omnes Capital European Venture Community: A handful of larger funds can focus on $5m+ gap Seventure Innovation Capital Auriga/ Ventech Edrip/ Banexi 7 Sofinova X-Ange GIMV Octopus Imperial innovations Wellington
  8. 8. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE 2013 >$5m deals (VentureSource) including follow-ons announced No Investor Deals Companies 1 Index Ventures 14 Elasticsearch B.V., Far-Fetch.com Ltd., Funding cirle Ltd, Gensight Biologics SA, MetaPack Ltd., Mind-NRG SA, MyOptique Group Ltd., Navabi GmbH, NumberFour AG, OncoEthix SA, Touchtype Ltd., TransferWise Ltd., XO1 Ltd., Trustpilot 2 DFJ Esprit LLP 9 M-Files Oy, Movidius, Neul Ltd., Sportpursuit, XMOS Ltd., ZBD Displays, Aveillant, Trustpilot, Lyst 2 Sofinnova Partners 9 Green Biologics Ltd., Hookipa Biotech AG, McPhy Energy SA, MedDay SAS, Mission therapeutics Ltd., ObsEva SA, Pixium Vision SA, Auris Medical AG, Crescendo Biologics Ltd., Crocus Technology SA 2 Ventech SA 9 JH Group SA, Shopmium SAS, Vestiaire Collective SA, Withings SAS, ActogeniX NV, Ad Valem Technologies SAS, BonitaSoft SA, Covagen AG, Crocus Technology SA 3 IDInvest Partners 8 Vestiaire collective, Withings, Crocus Technology, Gential SA, Grand Cru OY, PathoQuest SAS, Plumbee, STAT- Diagnostica & Innovation SL 3 Omnes Capital 8 Complix NV, Cooltech Applications, EyeTech Care, Futuris SpA, Gecko Biomedical SAS, Opsona Therapeutics, Pixium Vision, Supersonic Imagine 4 EdRIP (Rothschild) 7 OncoEthix SA, SuperSonic Imagine SA, Allecra Therapeutics GmbH, Complix NV, Covagen AG, Genticel SA, Jenavalve Technology GmbH 4 Wellington Partners 7 SuperSonic Imagine, EyeEm Mobile, Genticel SA, Hailo Network, Immatics Biotechnologies, LeanWorks, Middle Peak Medical 4 Accel partners 7 Touchtype, Calastone, Shopmium, Friendly Fashion, Hailo Network, Funding Circle, Lyst 5 Gimv NV 6 ActoGeniX NV, Complix NV, Covagen AG, JenaValve Technology, Multiplicon NV, PlanetVeo/Prestige Voyages 5 Iris Capital 6 iMediapp SAS, Mister-Auto SAS, Netatmo SAS, PlanetVeo/Prestige Voyages, rebuy reCommerce, DelfMems 5 Seventure Partners 6 Middle Peak Medical, Navali GmbH, Recommerce Solutions, STUDITEMPS, Advanced accelerator Applications, EndoControl 5 Xange Private Equity 6 Mister Spex, Mobile’S Republic, mysportgroup, NovaWatt, STUDITEMPS, Compario 5 Balderton 6 GoCardless, Vestaire Collective, Worldstores, MBA Polymers, Abiquo, Lyst 6 Forbion Capital Partners 5 UniQure, Allecra Therapeutics, Curetis, Dezima Pharma, Hookipa Biotech 6 Imperial Innovations 5 Crescendo Biologics, Econic Technologies, Mission Therapeutics, Plaxica, Pulmocide 6 Octopus Ventures 5 Kabbee Exchange, Leanworks, Touchtype, Amplience, Calastone DFJE in top 10 most active later stage VCs ($5m+ deals, primary and secondary follow-ons) 8
  9. 9. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE CurrentInvestments Enterprise Software Digital Media & Internet Hardware & Electronics NextGen Telecom & Mobile Health and Wellness PreviousExits (IPO) * * * * * * * * * * * * * * * * * * Fund 3 deal * * * * Well Balanced Portfolio Cross Stage, Industry & Geography 9 (IPO)
  10. 10. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE10 Secondaries: 9 portfolio Deals, 140+ Companies August 2004 Acquisition of WestLB AG European venture portfolio 19 companies3 December 2005 Acquisition of Siemens AG wireless venture portfolio2 19 companies 3 February 2006 Acquisition of a UK Technology venture portfolio 4 companies 3 Undisclosed March 2006 Spinout of Cazenove European venture portfolio 35 companies £80,000,000 April 2006 Acquisition of Viventures 2 venture portfolio 14 companies 3 March 2008 Acquisition of The Prelude Trust 14 companies Public to Private £50,000,000 May 2008 Acquisition of venture assets From BNP-Paribas 3 companies3 September 2009 Acquisition of 3i European venture portfolio 22 companies £170,000,000 April 2012 Acquisition of Top Technology venture assets 8 companies3 1 On 1 Jan 2012, DFJ Esprit and Tempo Capital Partners joined forces to create DFJ Esprit Secondaries 2 Co-advisors: smac partners GmbH 3 Consideration undisclosed Tempo Capital 1 DFJ Esprit 1DFJ Esprit Secondaries
  11. 11. PRIVATE AND CONFIDENTIAL – DO NOT DISTRIBUTE For further information please contact: Simon Cook – CEO , DFJ Esprit Tel: +44 207 931 8800 DFJ Esprit LLP www.dfjesprit.com 14 Buckingham Gate London, SW1E 6LB United Kingdom 11

×